| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -82.48 M USD | -18.29 M USD | -36.91 M USD | -10.40 M USD | -2.84 M USD | -3.64 M USD | -5.05 M USD | -5.71 M USD | -5.71 M USD | -3.88 M USD | -3.52 M USD | -3.23 M USD |
| Depreciation & Amortization | 3.25 M USD | 2.31 M USD | 986000 USD | 267000 USD | 149000 USD | 147000 USD | 136000 USD | 80000 USD | 68000 USD | 470851 USD | 576380 USD | 685396 USD |
| Stock-Based Compensation | 8.97 M USD | 5.39 M USD | 3.74 M USD | 983000 USD | 386000 USD | 495000 USD | 420000 USD | 404000 USD | 372000 USD | 290312 USD | 205264 USD | 185987 USD |
| Capital Expenditures | 12.75 M USD | 54.41 M USD | 1.07 M USD | 282000 USD | 381000 USD | 273000 USD | 444000 USD | 337000 USD | 549000 USD | 479215 USD | 133305 USD | 19029 USD |
| Cash Flow from Investing | 41.23 M USD | -218.93 M USD | 24.37 M USD | -28.99 M USD | -410000 USD | -287000 USD | 401000 USD | 1.86 M USD | 1.51 M USD | 8.76 M USD | 783660 USD | -15.44 M USD |
| Cash Flow from Financing | 10.30 M USD | 289.38 M USD | 785000 USD | 28000 USD | 64.68 M USD | 994000 USD | 7.37 M USD | 521000 USD | -9000 USD | 39000 USD | 284865 USD | 23.45 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -95.23 M USD | -72.71 M USD | -37.98 M USD | -10.68 M USD | -3.22 M USD | -3.91 M USD | -5.49 M USD | -6.05 M USD | -6.26 M USD | -4.36 M USD | -3.66 M USD | -3.25 M USD |
Perspective Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics and technologies to treat various diseases, primarily within the oncology sector. Its primary function is to advance research that can lead to practical cancer treatment solutions, potentially impacting patient care significantly. The company engages in developing novel targeted therapies, often collaborating with leading research institutions and utilizing cutting-edge scientific techniques. Perspective Therapeutics Inc. plays a critical role in the healthcare market by addressing unmet medical needs and contributing to the growing demand for personalized medicine approaches. The work undertaken by the company holds substantial importance for the biotech and pharmaceutical industries as it seeks to improve therapeutic outcomes and enhance medical capabilities in combating cancer and other serious illnesses. The company's initiatives not only underscore the importance of biotechnology in advancing healthcare solutions but also highlight the ongoing evolution within the medical research landscape.